Article Information
History
- June 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Barbara Batista Salgado1,
- Fábio Carmona de Jesus Maués1,
- Maele Jordão1,
- Renato Lemos Pereira1,2,
- Daniel A. Toledo-Teixeira3,
- Pierina L. Parise3,
- Fabiana Granja3,4,
- Higo Fernando Santos Souza5,
- Marcio Massao Yamamoto5,
- Jannifer Oliveira Chiang6,
- Livia Caricio Martins6,
- Silvia Beatriz Boscardin5,
- Jaila Dias Borges Lalwani7,
- Pedro Fernando C Vasconcelos8,
- José Luiz Proença-Modena3,9 and
- Pritesh Lalwani1,#
- 1Leônidas e Maria Deane Institute (ILMD), Fiocruz Amazônia, Manaus, Amazonas, Brazil
- 2Centro de Instrução de Guerra na Selva (CIGS), Manaus, Amazonas, Brazil
- 3Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, São Paulo, Brazil
- 4Biodiversity Research Center, Federal University of Roraima, Roraima, Brazil
- 5Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil
- 6Evandro Chagas Institute (IEC), Arbovirology and Hemorrhagic Fever Sector, Ananindeua, Pará, Brazil
- 7Pharmaceutical Science College (FCF), Federal University of Amazonas (UFAM), Manaus, Amazonas, Brazil
- 8Department of Pathology, Para State University, Belém, Pará, Brazil
- 9Experimental Medicine Research Cluster (EMRC), University of Campinas, Campinas, São Paulo, Brazil
- ↵#Corresponding author Contact Information: Instituto Leônidas e Maria Deane, Fiocruz Amazônia Rua Terezina 476, Adrianópolis. Manaus - AM. CEP: 69.057-070., Email: pritesh.lalwani{at}fiocruz.br
Posted June 08, 2022.
Antibody cross-reactivity and evidence of susceptibility to emerging Flaviviruses in the dengue-endemic Brazilian Amazon
